Fountainhead AM’s BlackRock Health Sciences Trust BME Stock Holding History

Fountainhead AM’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,285	Closed	-$204K	–	216
2025 Q1	$204K	Buy	+5,285	New	+$210K	0.03%	178
2024 Q4	–	Sell	-4,863	Closed	-$204K	–	171
2024 Q3	$204K	Buy	+4,863	New	+$202K	0.04%	139

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $313M AUM 13.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Fountainhead AM's BME Position: Q2 2025 in Review

Fountainhead AM sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 5,285 shares — an estimated $204K sold.

Fountainhead AM first reported a position in BME in Q3 2024 and held it in 2 quarters. The position peaked at $204K in Q1 2025. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

Fountainhead AM reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
Fountainhead AM sold 5,285 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $204K.
Fountainhead AM first reported a position in BlackRock Health Sciences Trust in Q3 2024 and held it in 2 quarters.
Fountainhead AM's BlackRock Health Sciences Trust position peaked at $204K in Q1 2025.
72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on Fountainhead AM's 13F filing for Q2 2025, filed 7 Aug 2025.